中国医药玻璃包装市场，按材料（I 型、II 型、III 型）、产品（瓶、安瓿、药筒和注射器、小瓶和其他）、药品类型（仿制药、品牌药、生物制剂）、应用（口服、注射剂、鼻腔剂、其他）、最终用途（制药公司、生物制药公司、合同开发和制造公司、复合药房、其他）、市场趋势和预测到 2028 年。
市场分析与洞察：中国医药玻璃包装市场
中国药用玻璃包装市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 7.8%，预计到 2028 年将达到 644,097.16 万美元。
推动市场发展的是人们健康意识的增强和液体药物储存新技术的采用。整体药品包装成本的增加对市场产生了制约作用。即用型玻璃瓶需求的不断增长为药用玻璃包装制造提供了机遇。政府对药用玻璃包装日益严格的监管对制造商来说可能是一个挑战。
本药用玻璃包装市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报；我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
中国医药玻璃包装市场范围及市场规模
药用玻璃包装市场根据材料、产品、药物类型、应用和最终用途进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据材料，市场分为 I 型、II 型和 III 型。在中国，I 型占据主导地位，因为其在药物制剂储存方法中的使用越来越多，从而扩大了其消费量。
- 根据产品，市场分为瓶子、安瓿瓶、药筒和注射器、小瓶和其他。在中国，由于对产品密封性的需求不断增加，瓶子市场占主导地位。
- 根据药物类型，市场分为仿制药、品牌药和生物药。在中国，仿制药占主导地位，因为年轻人和老年人群体的使用率都在增长。
- 根据应用，市场分为鼻腔、口服、注射和其他。在中国，口服占据主导地位，因为终端用户的产品消费量不断增加。
- 根据最终用户，市场分为制药公司、生物制药公司、合同开发和制造公司、复合药房和其他。在中国，由于持续的疫情，制药行业增长迅速，预计制药公司将主导市场。
医药玻璃包装市场国家层面分析
药用玻璃包装市场根据材料、产品、药品类型、应用和最终用途进行细分。
由于该地区制药行业对包装的需求不断增长，中国药用玻璃包装市场占据主导地位。
中国医药玻璃包装市场按药品类型划分
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了中国品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战，销售渠道的影响。
疫情期间医药玻璃包装行业的增长
中国药用玻璃包装市场还为您提供每个国家药用玻璃包装市场不同类型产品安装基数增长的详细市场分析、使用生命线曲线的技术影响以及婴儿配方奶粉监管情景的变化及其对药用玻璃包装市场的影响。数据适用于 2010 年至 2019 年的历史时期。
竞争格局和药用玻璃包装市场份额分析
中国药用玻璃包装市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、品牌分析、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对中国药用玻璃包装市场的关注有关。
报告涵盖的主要参与者包括 NIPRO、Gerresheimer AG、SGD Pharma（圣戈班的子公司）、山东省药用玻璃有限公司、Bormioli Pharma Spa、泰安优利实业有限公司、SCHOTT AG、FRIGOGLASS 以及其他国内外参与者。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
例如，
- 2020年，山东省药用玻璃有限公司被评为中国轻工业日用玻璃行业十强企业第三名。此次更新有助于公司增加客户群，从而为公司创造收入
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MATERIAL TYPE LIFE LINE CURVE
2.7 MULTIVARIATE MODELLING
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 DBMR MARKET CHALLENGE MATRIX
2.12 IMPORT-EXPORT DATA
2.13 SECONDARY SOURCES
2.14 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 CHINA:
4.2 MIDDLE EAST AND AFRICA:-
4.3 INDIA:
4.4 RUSSIA:
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 EXTENSIVE UTILIZATION OF GENERIC INJECTABLE DRUGS
5.1.2 GROWING ENVIRONMENTAL CONCERNS ASSOCIATED WITH PLASTIC PACKAGING
5.1.3 INCREASING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR STORAGE OF LIQUID DRUGS
5.2 RESTRAINTS
5.2.1 CHEMICAL RELEASE FROM THE INTERNAL SURFACE OF GLASS CONTAINERS
5.2.2 INCREASING COST OF OVERALL DRUG PACKAGING AND HANDLING
5.3 OPPORTUNITIES
5.3.1 GROWING DEMAND FOR READY-TO-USE GLASS VIALS FOR FLEXIBLE ASEPTIC FILLING
5.3.2 INCREASING DEMAND FOR THE PHARMACEUTICAL GLASS PACKAGING DURING PANDEMIC
5.4 CHALLENGE
5.4.1 STRINGENT GOVERNMENT REGULATIONS RELATING TO THE PHARMACEUTICAL INDUSTRY
6 IMPACT OF COVID-19 ON THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
6.1 AFTERMATH OF COVID-19 AND GOVERNMENT INITIATIVE TO BOOST THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
6.2 STRATEGIC DECISIONS FOR MANUFACTURERS AFTER COVID-19 TO GAIN COMPETITIVE MARKET SHARE
6.3 PRICE IMPACT
6.4 IMPACT ON DEMAND
6.5 IMPACT ON SUPPLY CHAIN
6.6 CONCLUSION
7 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL
7.1 OVERVIEW
7.2 TYPE I
7.3 TYPE II
7.4 TYPE III
8 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 BOTTLES
8.2.1 SMALL BOTTLES
8.2.2 LARGE BOTTLES
8.3 AMPOULES
8.4 CARTRIDGES & SYRINGES
8.5 VIALS
8.5.1 VIALS BY CAP SIZE
8.5.1.1-400 MM
8.5.1.2-425 MM
8.5.1.3-425MM
8.5.1.4-350 MM
8.5.1.5-400MM
8.5.1.6 8-425MM
8.5.1.7 9MM
8.5.1.8 OTHERS
8.5.2 VIALS BY CAPACITY
8.5.2.1 ML
8.5.2.2 8ML
8.5.2.3 4 ML
8.5.2.4 3 ML
8.5.2.5 2 ML
8.5.2.6 1 ML
8.5.2.7 ML
8.5.2.8 ML
8.5.2.9 ML
8.5.2.10 OTHERS
8.6 OTHERS
9 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE
9.1 OVERVIEW
9.2 GENERIC
9.3 BRANDED
9.4 BIOLOGIC
10 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 ORAL
10.3 INJECTABLE
10.4 NASAL
10.5 OTHERS
11 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE
11.1 OVERVIEW
11.2 PHARMACEUTICAL COMPANIES
11.3 BIOPHARMACEUTICAL COMPANIES
11.4 CONTRACT DEVELOPMENT AND MANUFACTURING COMPANIES
11.5 COMPOUND PHARMACY
11.6 OTHERS
12 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION
12.1 CHINA
13 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 WEST PHARMACEUTICAL SERVICES, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT UPDATE
15.2 CORNING INCORPORATED
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT UPDATES
15.3 GERRESHEIMER AG
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT UPDATE
15.4 NIPRO
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT UPDATE
15.5 FRIGOGLASS
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT UPDATE
15.6 SGD PHARMA (A SUBSIDIARY OF SAINT-GOBAIN)
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT UPDATE
15.7 MIDDLE EAST GLASS - MEG
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT UPDATE
15.8 HINDUSTAN NATIONAL GLASS & INDUSTRIES LIMITED.
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT UPDATE
15.9 SCHOTT AG
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT UPDATE
15.1 APG
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT UPDATE
15.11 BORMIOLI PHARMA S.P.A.
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT UPDATE
15.12 RAK GHANI GLASS LLC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT UPDATE
15.13 SHANDONG PROVINCE MEDICINAL GLASS CO., LTD.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT UPDATE
15.14 TAIAN YOULYY INDUSTRIAL CO., LTD.
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT UPDATE
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 IMPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 2 EXPORT DATA OF PRODUCT: 7010 CARBOYS, BOTTLES, FLASKS, JARS, POTS, PHIALS, AMPOULES AND OTHER CONTAINERS, OF GLASS, OF A.....HS CODE: 7010 (USD THOUSAND)
TABLE 3 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (USD THOUSAND)
TABLE 4 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (THOUSAND UNITS)
TABLE 5 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 6 CHINA BOTTLES IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 7 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAP SIZE, 2019-2028 (USD THOUSAND)
TABLE 8 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAPACITY, 2019-2028 (USD THOUSAND)
TABLE 9 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)
TABLE 10 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 11 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE, 2019-2028 (USD THOUSAND)
TABLE 12 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (USD THOUSAND)
TABLE 13 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2019-2028 (THOUSAND UNITS)
TABLE 14 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 15 CHINA BOTTLES IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT, 2019-2028 (USD THOUSAND)
TABLE 16 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAP SIZE, 2019-2028 (USD THOUSAND)
TABLE 17 CHINA VIALS IN PHARMACEUTICAL GLASS PACKAGING MARKET, BY CAPACITY, 2019-2028 (USD THOUSAND)
TABLE 18 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE, 2019-2028 (USD THOUSAND)
TABLE 19 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION, 2019-2028 (USD THOUSAND)
TABLE 20 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE, 2019-2028 (USD THOUSAND)
图片列表
FIGURE 1 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: SEGMENTATION
FIGURE 2 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: DATA TRIANGULATION
FIGURE 3 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: DROC ANALYSIS
FIGURE 4 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: CHINA VS REGIONAL MARKET ANALYSIS
FIGURE 5 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: MATERIAL LIFE LINE CURVE
FIGURE 7 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 11 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: SEGMENTATION
FIGURE 12 INCREASING HEALTH AWARENESS AND ADOPTION OF NEW TECHNIQUES FOR THE STORAGE OF LIQUID DRUGS IS DRIVING THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 TYPE I IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE CHINA PHARMACEUTICAL GLASS PACKAGING MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF CHINA PHARMACEUTICAL GLASS PACKAGING MARKET
FIGURE 15 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY MATERIAL, 2020
FIGURE 16 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: BY PRODUCT, 2020
FIGURE 17 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: BY DRUG TYPE, 2020
FIGURE 18 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY APPLICATION, 2020
FIGURE 19 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET, BY END-USE, 2020
FIGURE 20 CHINA PHARMACEUTICAL GLASS PACKAGING MARKET: COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
